Cargando…

Plasma Levels of Matrix Metalloproteinases 2 and 9 in Patients with Chronic Chagas Heart Disease and Systemic Arterial Hypertension: Correlation with TGF-Beta Plasma Levels

BACKGROUND: Chronic Chagas heart disease (CCHD) and systemic arterial hypertension (SAH) frequently coexists in areas where Chagas disease is endemic. The effects of the association of both conditions (CCHD-SAH) on the extracellular matrix (ECM) remodeling are unknown. Matrix metalloproteinases (MMP...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bestetti, Reinaldo B., Dellalibera-Joviliano, Renata, Rizzi, Ellen, Bonacio, Giselle F., Faria-Jr, Milton, Furlan-Daniel, Rosemeire, Castro-França, Suzeley
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2023
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10132902/ https://www.ncbi.nlm.nih.gov/pubmed/37122872 http://dx.doi.org/10.1155/2023/8484697

Ejemplares similares

Reductions of Circulating Nitric Oxide are Followed by Hypertension during Pregnancy and Increased Activity of Matrix Metalloproteinases-2 and -9 in Rats
por: Nascimento, Regina A., et al.
Publicado: (2019)

Obstructive Sleep Apnea: A Marker of Cardiac Remodeling in Patients with Chronic Chagas Disease
por: Bestetti, Reinaldo B.
Publicado: (2018)

Management of Cardiovascular Disease in Patients With COVID-19 and Chronic Chagas Disease: Implications to Prevent a Scourge Still Larger
por: Bestetti, Reinaldo Bulgarelli, et al.
Publicado: (2022)

Carlos Chagas Discoveries as a Drop Back to Scientific Construction of Chronic Chagas Heart Disease
por: Bestetti, Reinaldo B., et al.
Publicado: (2016)

Autonomic dysfunction and beta blocker therapy in Chagas heart disease
por: Bestetti, Reinaldo B, et al.
Publicado: (2013)

Cardiac resynchronization therapy for patients with chronic systolic heart failure secondary to Chagas cardiomyopathy in the 21(st) century
por: Bestetti, Reinaldo B.
Publicado: (2014)

Polymorphic Sites at the Immunoregulatory CTLA-4 Gene Are Associated with Chronic Chagas Disease and Its Clinical Manifestations
por: Dias, Fabrício C., et al.
Publicado: (2013)

Plasma Levels of Matrix Metalloproteinase-9 in Children With Chronic Spontaneous Urticaria
por: Dilek, Fatih, et al.
Publicado: (2016)

Plasma levels of matrix metalloproteinase-9 are elevated in individuals with hypertensive crisis
por: Valente, Flavia Mariana, et al.
Publicado: (2020)

Helminth Coinfection Is Associated With Enhanced Plasma Levels of Matrix Metalloproteinases and Tissue Inhibitor of Metalloproteinases in Tuberculous Lymphadenitis
por: Kathamuthu, Gokul Raj, et al.
Publicado: (2021)

Editorial: Intensive management of cardiovascular disease patients with confirmed or suspected COVID-19 in area where Chagas disease is endemic
por: Nakazone, Marcelo Arruda, et al.
Publicado: (2023)

Deficient Regulatory T Cell Activity and Low Frequency of IL-17-Producing T Cells Correlate with the Extent of Cardiomyopathy in Human Chagas' Disease
por: Guedes, Paulo Marcos Matta, et al.
Publicado: (2012)

Does left ventricular reverse remodeling influence long-term outcomes in patients with Chagas cardiomyopathy?
por: Nakazone, Marcelo Arruda, et al.
Publicado: (2022)

Effect of acute and chronic exercise on plasma matrix metalloproteinase and total antioxidant levels
por: Tunc-Ata, Melek, et al.
Publicado: (2017)

Clinical predictors of inducible sustained ventricular tachycardia during electrophysiologic study in patients with chronic Chagas' heart disease
por: Cardinalli-Neto, Augusto, et al.
Publicado: (2015)

Brazilian medical students’ perceptions of expert versus non-expert facilitators in a (non) problem-based learning environment
por: Couto, Lucélio B., et al.
Publicado: (2015)

MMP-2 and MMP-9 plasma levels are potential biomarkers for indeterminate and cardiac clinical forms progression in chronic Chagas disease
por: Medeiros, Nayara I., et al.
Publicado: (2019)

Association of Plasma Matrix Metalloproteinase and Tissue Inhibitors of Matrix Metalloproteinase Levels With Adverse Treatment Outcomes Among Patients With Pulmonary Tuberculosis
por: Kumar, Nathella P., et al.
Publicado: (2020)

Elevated Plasma Levels of Matrix Metalloproteinase-3 and Tissue-Inhibitor of Matrix Metalloproteinases-1 Associate With Organ Dysfunction and Mortality in Sepsis
por: Jones, Tiffanie K., et al.
Publicado: (2022)

Levels of matrix metalloproteinases differ in plasma and serum – aspects regarding analysis of biological markers in cancer
por: Jonsson, Andreas, et al.
Publicado: (2016)

Relationship between plasma matrix metalloproteinase levels, pulmonary function, bronchodilator response, and emphysema severity
por: Koo, Hyeon-Kyoung, et al.
Publicado: (2016)

Correlation Between Plasma Matrix Metalloproteinase-28 Levels and Severity of Calcific Aortic Valve Stenosis
por: Zhou, Ke, et al.
Publicado: (2020)

Plasma levels of matrix metalloproteinase‐9 (MMP‐9) are associated with cognitive performance in patients with schizophrenia
por: Kudo, Noriko, et al.
Publicado: (2020)

Genetic variations and plasma levels of gelatinase A (matrix metalloproteinase-2) and gelatinase B (matrix metalloproteinase-9) in proliferative diabetic retinopathy
por: Beránek, Michal, et al.
Publicado: (2008)

Assessment test before the reporting phase of tutorial session in problem-based learning
por: Bestetti, Reinaldo B, et al.
Publicado: (2017)

Bothrops jararaca Venom Metalloproteinases Are Essential for Coagulopathy and Increase Plasma Tissue Factor Levels during Envenomation
por: Yamashita, Karine M., et al.
Publicado: (2014)

Plasma levels of the tissue inhibitor matrix metalloproteinase-3 as a potential biomarker in oral cancer progression
por: Su, Chun-Wen, et al.
Publicado: (2017)

Plasma Levels of Metalloproteinase 3 (MMP-3) and Metalloproteinase 7 (MMP-7) as New Candidates for Tumor Biomarkers in Diagnostic of Breast Cancer Patients
por: Ławicki, Paweł, et al.
Publicado: (2023)

Association of the Functional MICA-129 Polymorphism With the Severity of Chronic Chagas Heart Disease
por: Ayo, Christiane Maria, et al.
Publicado: (2015)

Pharmacological Treatment of Patients with Mild to Moderate COVID-19: A Comprehensive Review
por: Bestetti, Reinaldo B., et al.
Publicado: (2021)

Plasma Cytokine Expression Is Associated with Cardiac Morbidity in Chagas Disease
por: Sousa, Giovane Rodrigo, et al.
Publicado: (2014)

Plasma Levels and Diagnostic Utility of Macrophage Colony-Stimulating Factor, Matrix Metalloproteinase-9, and Tissue Inhibitor of Metalloproteinases-1 as New Biomarkers of Breast Cancer
por: Ławicki, Sławomir, et al.
Publicado: (2016)

Relationship between Axial Length and Levels of TGF-β in the Aqueous Humor and Plasma of Myopic Patients
por: Hsiao, Yuwen, et al.
Publicado: (2021)

Elevated plasma levels of transforming growth factor (TGF)-beta1 and TGF-beta2 in patients with disseminated malignant melanoma.
por: Krasagakis, K., et al.
Publicado: (1998)

Levels of plasma matrix metalloproteinases (MMP-2 and MMP-9) in response to INTEGRA(®) dermal regeneration template implantation
por: Nessler, MichałBohdan, et al.
Publicado: (2014)

Polymorphisms and Plasma Levels of Tissue Inhibitor of Metalloproteinase-3: Impact on Genetic Susceptibility and Clinical Outcome of Oral Cancer
por: Su, Chun-Wen, et al.
Publicado: (2015)

High Level of Plasma Matrix Metalloproteinase-11 Is Associated with Clinicopathological Characteristics in Patients with Oral Squamous Cell Carcinoma
por: Hsin, Chung-Han, et al.
Publicado: (2014)

Call for Consensus in the Evaluation of Circulating Matrix Metalloproteinases in Chagas Disease
por: Bautista-López, Norma L., et al.
Publicado: (2022)

Prognostic Significance of Chronic Kidney Disease (CKD-EPI Equation) and Anemia in Patients with Chronic Heart Failure Secondary to Chagas Cardiomyopathy
por: Nakazone, Marcelo Arruda, et al.
Publicado: (2020)

TGF-β Polymorphisms Are a Risk Factor for Chagas Disease
por: Ferreira, Roberto Rodrigues, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_von3jp7qbe0loknake1a7bdl5e